<DOC>
	<DOCNO>NCT02466568</DOCNO>
	<brief_summary>The purpose study find effect ( good bad ) tumor vaccine ( GM.CD40L ) use combination Nivolumab participant cancer . Another purpose study find maximum tolerate dose nivolumab combination GM.CD40L vaccine . Investigators also want find combination GM.CD40L nivolumab boost immune system participant like , immune system reacts , treatment .</brief_summary>
	<brief_title>Study Nivolumab Combination With GM.CD40L Vaccine Adenocarcinoma Lung</brief_title>
	<detailed_description>This study two part participant may involve either Phase I part Phase II . Phase I : Investigators plan enroll participant cohorts 6 monitor side effect 21 day period determine maximum tolerate dose ( MTD ) nivolumab , give combination GM.CD40L . This do since study involve combination treatment study human find best dose Phase II part study . Phase II : Investigators plan compare clinical benefit participant receive combination GM.CD40L vaccine nivolumab , participant receive nivolumab .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Nivolumab</mesh_term>
	<criteria>Histologic cytologic diagnosis advanced/metastatic adenocarcinoma lung Eastern Cooperative Oncology Group ( ECOG ) performance status 0/1 Chemotherapy na√Øve complete adjuvant chemotherapy nonsmall cell lung cancer ( NSCLC ) &gt; 6 month prior Adequate bone marrow , renal hepatic function Must measurable metastatic disease accord Response Evaluation Criteria Solid Tumors ( RECIST ) v1.1 criterion Mandatory archival tissue willingness undergo fresh biopsy Life expectancy great 6 month Symptomatic brain metastasis uncontrolled central nervous system ( CNS ) metastasis Pregnancy breast feed Serious uncontrolled medical disorder active infection would impair participant 's ability receive study treatment Prior use PD1 PDL1 inhibitor Concurrent use anticancer approve investigational agent allow Autoimmune disorder Prior malignancy past 2 year Systemic steroid dos great 10 mg/day prednisone equivalent Any preexisting immunodeficiency condition ( include know HIV infection )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>advanced</keyword>
	<keyword>metastatic</keyword>
	<keyword>lung disease</keyword>
	<keyword>adenocarcinoma</keyword>
	<keyword>non-small cell lung cancer ( NSCLC )</keyword>
</DOC>